RSS   Newsletter   Contact   Advertise with us
Post Online Media

Cumberland Pharma announces Kenneth J. Krogulski to join its board

Cumberland PharmaCumberland Pharmaceuticals Inc., a specialty pharmaceutical company, announces the addition of Kenneth J. Krogulski to its board of directors, effective January 18, 2017.

Mr. Krogulski is the President and Chief Executive Officer of Berkshire Asset Management LLC. He is also the Chief Investment Officer of Berkshire, a 30-year-old independent SEC registered investment advisory firm.

Mr. Krogulski has over 37 years' experience in security analysis and portfolio management.

Mr. Krogulski began his career in finance at First Eastern Bank (now PNC Financial) as an investment analysis and portfolio manager. He then served as senior portfolio manager in First Easter's Trust department.

Mr. Krogulski then joined Berkshire and later led a management buy-out acquiring the company from Legg Mason.

He earned his B.S. in finance from Indiana University of Pennsylvania and his M.B.A from Wilkes University. He holds the Chartered Financial Analysts designation.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy